Nasdaq IPOs

Skillful Craftsman Education Technology, which provides online education and technology services in China, increased its proposed range and decreased its proposed share offering for its upcoming IPO on Monday. The Jiangsu, China-based company still plans to raise $15 million, but

Inari Medical, which makes minimally invasive medical devices for venous diseases, announced terms for its IPO on Monday. The Irvine, CA-based company plans to raise $110 million by offering 7.3 million shares at a price range of $14 to $16. Insiders intend to purchase $20 millio

The largest US IPO since February and a SPAC are on the calendar for the week ahead. SelectQuote (SLQT), an online platform for comparing and purchasing insurance, plans to raise $450 million at a $3.0 billion market cap. The deal marks the largest IPO by a US company since PPD'

One biotech and three SPACs went public this past week as the IPO market shows more signs of opening up. The VIX volatility index is hovering around 30, the IPO index is now up 58% from its March lows, and eight companies submitted initial filings, the most since late February. S

Shift4 Payments, which provides secure payment processing solutions, filed on Friday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $300 million. Shift4 Payments' main business

Mountain Crest Acquisition, a blank check company focusing on acquiring a private equity portfolio company, filed on Friday with the SEC to raise up to $50 million in an initial public offering. The New York, NY-based company plans to raise $50 million by offering 5 million units

Shelter-in-place restrictions have delivery services companies riding a wave of demand ahead of planned 2020 IPOs. Leading the pack is China's Dada Nexus (DADA). This week Dada Nexus filed for a US IPO that we estimate could raise up to $500 million. Privately valued at abou

SelectQuote, which provides a platform for consumers to compare and buy insurance online, announced terms for its IPO on Friday. The Overland Park, KS-based company plans to raise $450 million by offering 25 million shares (28% insider) at a price range of $17 to $19. At the midp

ADC Therapeutics, a Swiss Phase 2 biotech developing next-gen antibody drug conjugates for difficult-to-treat cancers, raised $233 million by offering 12.2 million shares at $19, above the range of $16 to $18. The company had originally filed to sell 7.4 million shares before ups

Novus Capital Corp, a blank check company targeting the smart technology innovations market, raised $100 million by offering 10 million units at $10. Units consist of one share of common stock and one warrant exercisable at $11.50. The Indianapolis, IN-based SPAC originally filed

GigCapital3, the third blank check company led by semiconductor veteran Avi Katz, raised $200 million by offering 20 million units at $10. Anchor investor Cohen & Co indicated on $17 million of the IPO (9% of the deal). Units consist of one share of common stock and 3/4 of on

Calliditas Therapeutics, a Swedish biotech developing novel therapies for inflammatory kidney disease, filed on Thursday with the SEC to raise up to $75 million in an initial public offering. The company's stock currently trades on the Nasdaq Stockholm under the symbol "CALTX" an

NuZee, which packages and sells single-serve coffee products, announced terms for its IPO on Thursday. In its latest filing, the company also disclosed financial results for the six months ended March 31, 2020. The Plano, TX-based company plans to raise $5 million by offering 555

Jaws Acquisition, a blank check company led by Starwood Capital founder Barry Sternlicht, raised $600 million by offering 60 million units at $10. The company originally planned to offer 40 million units before increasing its proposed unit offering to 50 million last week. Each u

ADC Therapeutics, a Swiss Phase 2 biotech developing next-gen antibody drug conjugates for difficult cancers, increased the proposed share offering for its upcoming IPO on Thursday. The Épalinges, Switzerland-based company now plans to raise $175 million by offering 10.3 m

Legend Biotech, a clinical stage oncology biotech being spun-out of GenScript's cell therapy unit, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. Legend's extensive pipeline contains lead candidate LCAR-B38M/JNJ-4528, a CAR-T therapy be

Dada Nexus, a leading on-demand retail and delivery platform in China, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $500 million. Dada Nexus operat

Coro Global, which is developing a gold-focused payment application and financial security platform, filed on Tuesday with the SEC to raise up to $13 million in an initial public offering. The company is currently quoted on the OTC Pink under the symbol "CGLO" and last closed at

Lantern Pharma, a Phase 2 oncology biotech using AI to redevelop abandoned drugs for targeted groups, announced terms for its IPO on Tuesday. The Dallas, TX-based company plans to raise $25 million by offering 1.6 million shares at a price range of $15 to $17. At the midpoint of

Kiromic BioPharma, a preclinical biotech developing immunotherapies for blood cancers and solid tumors, filed on Monday with the SEC to raise up to $20 million in an initial public offering. Kiromic's pipeline consists of four early-stage product candidates targeting blood cancer